NCT04815733

Brief Summary

This study is a single-center, blind, prospective, randomized, controlled trial of pressure support ventilation (PSVpro) versus pressure control ventilation - volume guaranteed (PCV - VG) during laparoscopic and robotic abdominal surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2017

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

October 28, 2020

Completed
5 months until next milestone

First Posted

Study publicly available on registry

March 25, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2023

Completed
Last Updated

April 26, 2023

Status Verified

April 1, 2023

Enrollment Period

5.8 years

First QC Date

October 28, 2020

Last Update Submit

April 25, 2023

Conditions

Keywords

pressure support ventilationanaesthesialung injurylaparoscopic surgery

Outcome Measures

Primary Outcomes (1)

  • Concentrations of biomarkers of lung injury

    Measure concentration of Interleukin-6 (IL-6), Interleukin-8 (IL-8), tumor necrosis factor receptor I / II (sTNF rI / II)) in blood serum

    1-3 hours after surgery

Secondary Outcomes (2)

  • Maximum intraoperative lactate level in the early postoperative period

    1 hour after surgery

  • The maximum level of vasopressor support during surgery

    From time of skin incision to time of skin closure assessed up to 24 hours

Other Outcomes (19)

  • Duration of anaesthesia.

    Period of time from induction to volatile anesthetic supply stop assessed up to 24 hours

  • Procedure time

    Period of time from intubation to extubation assessed up to 24 hours

  • Length of stay (LOS) in the intensive care unit (ICU).

    Period of time from ICU arrival to discharge from ICU assessed up to 1 year

  • +16 more other outcomes

Study Arms (2)

Mandatory ventilation

ACTIVE COMPARATOR

deep neuromuscular block and mandatory ventilation (PCV-VG);

Procedure: Mandatory ventilation

Pressure support ventilation

EXPERIMENTAL

partial neuromuscular block and pressure support ventilation (PSVpro).

Procedure: pressure support ventilation

Interventions

Use PCV-VG

Mandatory ventilation

Use PSVpro

Pressure support ventilation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Written consent.
  • Men and women aged 18 years or more.
  • The physical status from ASA classification I, II or III.
  • BMI \<= 34.9 kg / m2.
  • Low risk of respiratory complications.
  • Laparoscopic surgery in the pelvis.

You may not qualify if:

  • The physical status from ASA IV or V.
  • BMI\> = 35 kg / m2.
  • Neuromuscular disease.
  • Allergy to Anesthetic Agents.
  • Operations on two cavities.
  • Operations on the chest cavity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Moscow Clinical Scientific Center

Moscow, Russia

Location

MeSH Terms

Conditions

Ventilator-Induced Lung InjuryLung Injury

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesThoracic InjuriesWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: t is planned to recruit patients in two groups: group 1-patients who will undergo General anesthesia with deep neuromuscular block and PCV-VG; group 2-patients with partial neuromuscular block and PSVpro. Randomization of patients into two 1:1 groups will be performed by random number generation.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

October 28, 2020

First Posted

March 25, 2021

Study Start

June 1, 2017

Primary Completion

March 31, 2023

Study Completion

March 31, 2023

Last Updated

April 26, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations